Cargando…

Sleep Quality Improvement Enhances Neuropsychological Recovery and Reduces Blood Aβ(42/40) Ratio in Patients with Mild–Moderate Cognitive Impairment

Background and objectives: Alzheimer’s disease is a progressive brain degeneration and is associated with a high prevalence of sleep disorders. Amyloid β peptide-42/40 (Aβ(42/40)) and Tau-pT181 are the core biomarkers in cerebrospinal fluid and blood. Accumulated data from studies in mouse models an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Haihua, Li, Mingqiu, Zhang, Menglin, Qiu, Jiang, Cheng, Haiyan, Mou, Xin, Chen, Qinghong, Li, Tina, Peng, Jun, Li, Benyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704453/ https://www.ncbi.nlm.nih.gov/pubmed/34946311 http://dx.doi.org/10.3390/medicina57121366

Ejemplares similares

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
por: Ávila, Renata, et al.
Publicado: (2007)

A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
por: Al- Ayadhi, Laila Y, et al.
Publicado: (2012)

Annual stability of the plasma Aß40/42 ratio and associated factors
por: Nakamura, Takumi, et al.
Publicado: (2023)

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40
por: Suire, Caitlin N., et al.
Publicado: (2020)

Normalized Cortisol Reactivity Predicts Future Neuropsychological Functioning in Children With Mild/Moderate Asthma
por: Dinces, Sarah M., et al.
Publicado: (2019)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Neuropsychological methods in mild cognitive impairment
por: Hahn-Barma, Valérie, et al.
Publicado: (2004)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
por: Campbell, Michelle R., et al.
Publicado: (2021)

Allosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β(42/40) Ratio
por: Uemura, Kengo, et al.
Publicado: (2009)

Aβ(42)/Aβ(40) and Aβ(42)/Aβ(38) Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer’s Disease: A Pilot Study
por: Koychev, Ivan, et al.
Publicado: (2018)

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
por: Baldeiras, Inês, et al.
Publicado: (2018)

Frontotemporal dementia is the leading cause of “true” A−/T+ profiles defined with Aβ(42/40) ratio
por: Pouclet-Courtemanche, Hélène, et al.
Publicado: (2019)

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
por: Altay, Ozlem, et al.
Publicado: (2021)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection
por: Petersen, Marvin, et al.
Publicado: (2023)

Mild cognitive impairment in adult: A neuropsychological review
por: Yanhong, Ouyang, et al.
Publicado: (2013)

Aspects Operationnels 40 41 et 42
por: Boutheon, M
Publicado: (1978)

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
por: Dumurgier, Julien, et al.
Publicado: (2015)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
por: Hansson, Oskar, et al.
Publicado: (2019)

Neurological soft signs in persons with amnestic mild cognitive impairment and the relationships to neuropsychological functions
por: Li, Hui-jie, et al.
Publicado: (2012)

Sleep Disorders Following Mild and Moderate Traumatic Brain Injury
por: Al-Ameri, Laith Thamer, et al.
Publicado: (2019)

Photorefractive keratectomy in mild to moderate keratoconus: Outcomes in over 40-year-old patients
por: Khakshoor, Hamid, et al.
Publicado: (2015)

Plasma Aβ(42):Aβ(40) ratio as a biomarker for cognitive impairment in haemodialysis patients: a multicentre study
por: Chen, Xujiao, et al.
Publicado: (2023)

Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias
por: Baiardi, Simone, et al.
Publicado: (2018)

Relationship between Sleep Quality and Cognitive Function in Patients with Mild-to-Moderate Parkinson's Disease
por: Liu, Hui-Miao, et al.
Publicado: (2018)

Evaluation and Treatment of Mild Traumatic Brain Injury: The Role of Neuropsychology
por: Prince, Carolyn, et al.
Publicado: (2017)

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM(R) Scale
por: Lehmann, Sylvain, et al.
Publicado: (2018)

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
por: Colletti, Tiziana, et al.
Publicado: (2021)

Experimental mass excess of $^{40}$Cl and $^{42}$Cl
por: Miehé, C, et al.
Publicado: (1989)

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer’s Disease and Mild Cognitive Impairment
por: Dong, Ningxin, et al.
Publicado: (2022)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory
por: Lewczuk, Piotr, et al.
Publicado: (2021)

Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury
por: Hossain, Iftakher, et al.
Publicado: (2020)

Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides
por: Wang, Li, et al.
Publicado: (2021)

The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone
por: Delaby, Constance, et al.
Publicado: (2022)

P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia
por: Parra, Mario A., et al.
Publicado: (2012)

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases
por: Hessen, Erik, et al.
Publicado: (2016)

Late-onset Huntington’s disease with 40–42 CAG expansion
por: Capiluppi, Elisa, et al.
Publicado: (2019)

Home EEG sleep assessment shows reduced slow‐wave sleep in mild–moderate Alzheimer's disease
por: Kent, Brianne A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_prm3v47f27bbnqfi73rhndmvr1